DTC
KYMR icon

Deep Track Capital’s Kymera Therapeutics KYMR Stock Holding History

Deep Track Capital’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-600,326
Closed -$28.4M – 73
2024
Q3 		$28.4M Sell
600,326
-899,674
-60% -$39.7M 0.9% 36
2024
Q2 		$44.8M Buy
1,500,000
+237,754
+19% +$8.23M 1.34% 28
2024
Q1 		$50.7M Buy
+1,262,246
New +$45.2M 1.45% 28

Other funds holding KYMR

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Deep Track Capital's KYMR Position: Q4 2024 in Review

Deep Track Capital sold out of Kymera Therapeutics (KYMR) in Q4 2024, closing a stake of 600,326 shares — an estimated $28.4M sold.

Deep Track Capital first reported a position in KYMR in Q1 2024 and held it in 3 quarters. The position peaked at $50.7M in Q1 2024. 180 funds tracked by Wall St. Rank hold KYMR as of Q4 2024.

  • Deep Track Capital reported no remaining Kymera Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Deep Track Capital sold 600,326 Kymera Therapeutics shares in Q4 2024, an estimated $28.4M.
  • Deep Track Capital first reported a position in Kymera Therapeutics in Q1 2024 and held it in 3 quarters.
  • Deep Track Capital's Kymera Therapeutics position peaked at $50.7M in Q1 2024.
  • 180 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q4 2024.

Based on Deep Track Capital's 13F filing for Q4 2024, filed 14 Feb 2025.